EMA Recommends Extension of Indications for Dostarlimab By Ogkologos - January 23, 2025 577 0 Facebook Twitter Google+ Pinterest WhatsApp Change concerns the first-line treatment of patients with endometrial cancer Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR New on NCI’s Websites for March 2021 March 25, 2021 Spirituality Resources December 9, 2020 My Path to Becoming a Radiation Therapist November 12, 2020 Prize winning early detection research October 7, 2021 Load more HOT NEWS The power of partnership – the unique alliance taking on brain... For Women With Dense Breasts, An MRI May Be A Better... Regular Exercise May Boost Immune Response and Improve Immunotherapy in Breast... FDA Approves Azacitidine for Newly Diagnosed Juvenile Myelomonocytic Leukaemia
